NCT05914792 Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit Surgery Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05914753 Evaluating Xihuang Pill to Improve the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer Status UNKNOWN Phase NA
NCT05914415 The Effect of Preoperative Education on Postoperative Healing Quality in Patients With Mastectomy Status UNKNOWN Phase NA
NCT05914402 Axillary Surgery De-escalation After Neoadjuvant Therapy Using Dedicate Breast PET Status RECRUITING Phase NA
NCT05913440 HER2-low Unresectable and/or Metastatic Breast Cancer in Russia Status COMPLETED Phase N/A
NCT05912933 A Study to Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib) Status COMPLETED Phase N/A
NCT05912062 Early On-treatment Transcriptional Profiling as Predictor of Response in Early-stage HER2-positive Breast Cancer Status UNKNOWN Phase N/A
NCT05911867 Muscle Energy Technique and Mulligan's Mobilization in Breast Cancer Surgery Patients Status UNKNOWN Phase NA
NCT05909813 Individualized Piano Instruction (IPI) for Improving Cognition in Breast Cancer Survivors. Status COMPLETED Phase NA
NCT05909397 Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05909332 Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03) Status RECRUITING Phase PHASE3
NCT05907681 Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M) Status RECRUITING Phase N/A
NCT05905939 HER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in Russia Status COMPLETED Phase N/A
NCT05905341 Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors. Status WITHDRAWN Phase PHASE1
NCT05904730 Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations Status COMPLETED Phase PHASE1